补充5-甲基四氢叶酸对哺乳期产妇健康及一碳代谢的影响 (OCMS)
5-甲基四氢叶酸补充对哺乳期母体健康和一碳代谢的影响
This double-blind, randomized, placebo-controlled parallel trial evaluates the effects of maternal 5-methyltetrahydrofolate (5-MTHF) supplementation during breastfeeding. Thirty-six lactating mother-infant dyads will be randomized (1:1) to receive 5-MTHF or placebo for 6 weeks, stratified by infant sex and mode of delivery. Tolerability and adverse events will be monitored.
Pre- and post-intervention assessments include breast milk one-carbon metabolites and oligosaccharides; maternal plasma one-carbon metabolites and metabolic health markers. Maternal mental health will be evaluated using the SCL-90-R questionnaire. A follow-up visit at 4 months will reassess infant anthropometry and microbiome outcomes.
研究概览
研究类型
注册 (估计的)
阶段
- 阶段2
- 阶段1
联系人和位置
学习联系方式
- 姓名:Carles Lerin, PhD
- 电话号码:(+34) 93 600 97 51
- 邮箱:carles.lerin@sjd.es
研究联系人备份
- 姓名:Marta Ramon Krauel, MD PhD
- 电话号码:Ext. 71263 (+34) 93 280 40 00
- 邮箱:marta.ramon@sjd.es
学习地点
-
-
Barcelona
-
Barcelona、Barcelona、西班牙、08950
- 招聘中
- Hospital Sant Joan de Deu
-
接触:
- Carles Lerin, PhD
- 电话号码:(+34) 93 600 97 51
- 邮箱:carles.lerin@sjd.es
-
Barcelona、Barcelona、西班牙、08950
- 尚未招聘
- Hospital Sant Joan de Déu
-
接触:
- Carles Lerin, PhD
- 电话号码:936009751 Spain
- 邮箱:carles.lerin@sjd.es
-
接触:
- Carles Lerin
- 电话号码:601106790 Spain
- 邮箱:carleslerin@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Maternal age between 18 and 42 years
- Gestational age at birth ≥ 37 weeks.
- Exclusive breastfeeding at enrollment.
- Infant age 0-1 months
Exclusion Criteria:
- Multiple pregnancy
- Presence of disease or malformations in the infant.
- Weight-Standard Deviation Score < -1 at enrollment.
- Use of folate-containing multivitamin supplements during breastfeeding
学习计划
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
安慰剂比较:Placebo
Placebo |
Matching placebo administered daily for 6 weeks during lactation. |
|
实验性的:5-MTHF Supplementation
Dietary Supplement (5-MTHF) |
Oral supplementation with 5-MTHF (800 µg) administered daily for 6 weeks during lactation. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of Adverse Events
大体时间:Baseline, 6 weeks, 4 months
|
Treatment safety and tolerability will be evaluated by assessing differences in the incidence of potential adverse events between groups, focusing on gastrointestinal symptoms. |
Baseline, 6 weeks, 4 months
|
|
Change in breast milk 5-MTHF concentration
大体时间:Baseline, 6 weeks
|
Change in breast milk 5-MTHF concentration measured with liquid chromatography coupled to mass spectrometry (LC-MS) from Baseline to 6 weeks. |
Baseline, 6 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in plasma 5-MTHF concentration
大体时间:Baseline, 6 weeks
|
Change in maternal plasma 5-MTHF concentration measured with liquid chromatography coupled to mass spectrometry (LC-MS) from Baseline to 6 weeks. |
Baseline, 6 weeks
|
|
Change in breast milk one-carbon metabolite concentration
大体时间:Baseline, 6 weeks
|
Change in breast milk one-carbon-related metabolites (choline, methionine, SAM, SAH, homocysteine, cystathionine, folic acid, betaine) from Baseline to 6 weeks. |
Baseline, 6 weeks
|
|
Change in plasma one-carbon metabolite concentration
大体时间:Baseline, 6 weeks
|
Change in plasma one-carbon-related metabolites (choline, methionine, SAM, SAH, homocysteine, cystathionine, folic acid, betaine) from Baseline to 6 weeks. |
Baseline, 6 weeks
|
|
Change in Human Milk Oligosaccharide (HMO) concentration
大体时间:Baseline, 6 weeks
|
Change in HMO concentrations between Baseline and 6 weeks |
Baseline, 6 weeks
|
|
Change in Maternal Plasma Glucose Concentration
大体时间:Baseline, 6 weeks
|
Change in maternal blood glucose levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Plasma Glycated Hemoglobin (HbA1c) Concentration
大体时间:Baseline, 6 weeks
|
Change in maternal blood glycated hemoglobin (HbA1c) between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Plasma Insulin Concentration
大体时间:Baseline, 6 weeks
|
Change in maternal blood insulin levels between Baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Plasma Triglyceride (TAG) Concentration
大体时间:Baseline, 6 weeks
|
Change in maternal blood triglyceride (TAG) levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Blood Total Cholesterol Concentration
大体时间:Baseline, 6 weeks
|
Change in maternal blood total Cholesterol levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Blood LDL Cholesterol Concentration
大体时间:Baseline, 6 weeks
|
Change in maternal low-density lipoprotein (LDL) cholesterol levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Blood HDL Cholesterol Concentration
大体时间:Baseline, 6 weeks
|
Change in maternal high-density lipoprotein (HDL) cholesterol levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Blood Alanine Aminotransferase (ALT) Levels
大体时间:Baseline, 6 weeks
|
Change in maternal alanine aminotransferase (ALT) levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Blood Aspartate Aminotransferase (AST) Levels
大体时间:Baseline, 6 weeks
|
Change in maternal aspartate aminotransferase (AST) levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Maternal Blood Gamma-Glutamyl Transferase (GGT) Levels
大体时间:Baseline, 6 weeks
|
Change in maternal gamma-glutamyl transferase (GGT) levels between baseline and 6 weeks. |
Baseline, 6 weeks
|
|
Change in Symptom Checklist-90-Revised (SCL-90-R) scale
大体时间:Baseline, 3 weeks
|
The SCL-90-R is a 90-item self-report questionnaire assessing psychological symptoms over the past week, with a range of 0-90 across 9 dimenions: Somatization, Obsessive-compulsive, Interpersonal sensitivity, Depression, Anxiety, Hostility, Phobic anxiety, Paranoid ideation, Psychoticism. Higher scores indicate worse outcome. |
Baseline, 3 weeks
|
|
Change in infant BMI z-score
大体时间:Baseline, 6 weeks
|
We will measure infant body weight, length, and head circumference to calculate BMI z-scores according to WHO growth standards, and changes between baseline, 6 weeks and 4 months will be assessed. |
Baseline, 6 weeks
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Maternal and infant gut microbiome composition
大体时间:Baseline, 6 weeks
|
Bacterial DNA will be isolated from infant and maternal fecal samples and sequenced to obtain microbiome composition. |
Baseline, 6 weeks
|
|
Maternal plasma and breast milk metabolomic profile
大体时间:Baselina, 6 weeks
|
The metabolomic profile will be obtained with the Biocrates Quant 1000 kit from plasma and breast milk samples. |
Baselina, 6 weeks
|
|
Milk imprinted protein levels
大体时间:Baseline, 6 weeks
|
Imprinted proteins in human milk samples will be analyzed by ELISA. |
Baseline, 6 weeks
|
合作者和调查者
调查人员
- 首席研究员:Carles Lerin, PhD、Fundació Sant Joan de Déu
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.